Omalizumab is a monoclonal antibody used to treat allergic asthma and chronic spontaneous urticaria. It works by binding to IgE antibodies, preventing them from triggering allergic reactions. Omalizumab is effective in reducing asthma attacks and improving quality of life for patients with allergies. Common side effects may include injection site reactions and headaches, but these typically resolve over time. In summary, Omalizumab is crucial for managing allergic conditions.
Omalizumab binds to free IgE, preventing it from binding to mast cells and basophils, thereby inhibiting allergic inflammation.
No published brands for this salt yet.